Detection of CFTR function and modulation in primary human nasal cell spheroids.

[1]  J. Rajagopal,et al.  Personalized medicine for cystic fibrosis: Establishing human model systems , 2015, Pediatric pulmonology.

[2]  Xiaohong Huang,et al.  Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR. , 2015, The New England journal of medicine.

[3]  Viktoria Elkis,et al.  Development of glandular models from human nasal progenitor cells. , 2015, American journal of respiratory cell and molecular biology.

[4]  H. Janssens,et al.  A bioassay using intestinal organoids to measure CFTR modulators in human plasma. , 2015, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[5]  C. Boinot,et al.  Searching for Combinations of Small-Molecule Correctors to Restore F508del–Cystic Fibrosis Transmembrane Conductance Regulator Function and Processing , 2014, The Journal of Pharmacology and Experimental Therapeutics.

[6]  S. McColley,et al.  A CFTR corrector (lumacaftor) and a CFTR potentiator (ivacaftor) for treatment of patients with cystic fibrosis who have a phe508del CFTR mutation: a phase 2 randomised controlled trial. , 2014, The Lancet. Respiratory medicine.

[7]  R. Szczesniak,et al.  Multicenter Intestinal Current Measurements in Rectal Biopsies from CF and Non-CF Subjects to Monitor CFTR Function , 2013, PloS one.

[8]  Hans Clevers,et al.  A functional CFTR assay using primary cystic fibrosis intestinal organoids , 2013, Nature Medicine.

[9]  Chris Albanese,et al.  ROCK inhibitor and feeder cells induce the conditional reprogramming of epithelial cells. , 2012, The American journal of pathology.

[10]  Matthias Griese,et al.  A CFTR potentiator in patients with cystic fibrosis and the G551D mutation. , 2011, The New England journal of medicine.

[11]  P. Negulescu,et al.  Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809 , 2011, Proceedings of the National Academy of Sciences.

[12]  J. Clancy,et al.  Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutation , 2011, Thorax.

[13]  F. van Goor,et al.  Use of primary cultures of human bronchial epithelial cells isolated from cystic fibrosis patients for the pre-clinical testing of CFTR modulators. , 2011, Methods in molecular biology.

[14]  R. Boucher,et al.  Evidence for airway surface dehydration as the initiating event in CF airway disease , 2007, Journal of internal medicine.

[15]  J. Pilewski,et al.  Role of CFTR in airway disease. , 1999, Physiological reviews.

[16]  D. Benos,et al.  CFTR is a conductance regulator as well as a chloride channel. , 1999, Physiological reviews.

[17]  P. S. Pedersen,et al.  Ion transport in epithelial spheroids derived from human airway cells. , 1999, American journal of physiology. Lung cellular and molecular physiology.

[18]  Matthew P. Anderson,et al.  Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive , 1992, Nature.

[19]  R. Harris,et al.  Cultured human nasal epithelial multicellular spheroids: polar cyst-like model tissues. , 1991, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[20]  M. Welsh.  An apical-membrane chloride channel in human tracheal epithelium. , 1986, Science.

[21]  J. Gustafson,et al.  Cystic Fibrosis , 2009, Journal of the Iowa Medical Society.